Skip to main content
VCbacked
Log inGet Started

Corner Therapeutics

Watertown, United States

Corner Therapeutics is a biotechnology research company that specializes in the immunotherapy paradigm.

$54.0M raised
Apr 2024
Series A
BiotechnologyHealth CareLife Science

Top Investors

Bill & Melinda Gates FoundationTanis venturesZiff Capital PartnersCockrell InterestsSandia Holdings

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Corner Therapeutics

How much funding has Corner Therapeutics raised?
Corner Therapeutics has raised $54.0M in total funding. The most recent round was Series A. The last funding was announced in April 2024.
Who are Corner Therapeutics's investors?
Corner Therapeutics's investors include Bill & Melinda Gates Foundation, Tanis ventures, Ziff Capital Partners, Cockrell Interests, Sandia Holdings.
Where is Corner Therapeutics headquartered?
Corner Therapeutics is headquartered in Watertown, United States.
What does Corner Therapeutics do?
Corner Therapeutics is a biotechnology research company that specializes in the immunotherapy paradigm.
What stage is Corner Therapeutics at?
Corner Therapeutics is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Corner Therapeutics — Funding & Investors." VCBacked, April 18, 2024, https://www.vcbacked.co/company/corner-therapeutics. Accessed June 17, 2026.
APA
VCBacked. (2024). Corner Therapeutics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/corner-therapeutics
Wikipedia (cite web)
{{cite web |title=Corner Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/corner-therapeutics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong